Loading insider details...
Beta
Latest Form 4 (Sep 4, 2026): Disposition to Issuer of 219,561 ADXN shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 4, 2026 | Addex Therapeutics Ltd. (ADXN) | Disposition to Issuer | 219,561 | n/a |
| Jun 17, 2026 | Zenas BioPharma, Inc. (ZBIO) | Grant/Award | 18,500 | n/a |
| Oct 14, 2025 | Zenas BioPharma, Inc. (ZBIO) | Purchase | 63,158 | $1.20M |
| Jun 12, 2025 | Zenas BioPharma, Inc. (ZBIO) | Grant/Award | 18,500 | n/a |
| Sep 17, 2024 | Zenas BioPharma, Inc. (ZBIO) | Conversion | 1,505,388 | n/a |
| Jun 14, 2024 | TREVENA INC (TRVN) | Grant/Award | 13,700 | n/a |
| May 21, 2024 | Regulus Therapeutics Inc. (RGLS) | Grant/Award | 60,000 | n/a |
| May 17, 2024 | Regulus Therapeutics Inc. (RGLS) | Grant/Award | 30,000 | n/a |